Myomo Inc. MYO
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $10.00 (+495.2% upside)
Key Stats
- Today's Range
- $1.52 – $1.70
- 50-Day Range
- $0.88 – $1.80
- 52-Week Range
- $0.60 – $2.22
- Volume
- 722K shs
- Average Volume
- 541K shs
- Market Cap
- $62.18 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 10.67
- Price / Sales
- 1.44
Short Interest
- Short Interest
- 1.84%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $43.26 million
- Net Income
- $-14,507,612
- Net Margin
- -33.53%
- Return on Equity
- -248.87%
- Debt-to-Equity
- 1.98
About Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Related Stocks
Compare head-to-head: MYO vs STE·MYO vs ZBH·MYO vs MSA·MYO vs SMTI
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.